Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).

@article{Podrini2013RedoxHA,
  title={Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).},
  author={Christine Podrini and Michela Borghesan and Azzura Greco and Valerio Pazienza and Gianluigi Mazzoccoli and Manlio Vinciguerra},
  journal={Current pharmaceutical design},
  year={2013},
  volume={19 15},
  pages={
          2737-46
        }
}
Non-alcoholic fatty liver disease (NAFLD), an accumulation of intra-hepatic triglycerides that is often considered the hepatic manifestation of insulin resistance, is the most common cause of chronic liver disease in the Western countries with up to one third of the population affected. NAFLD is a spectrum of disturbances that encompasses various degrees of liver damage ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). NASH is characterized by hepatocellular injury… CONTINUE READING